FindTrial
Sign In

Effect of Bone Marrow Mesenchymal Stem Cell on GMFM Scores of Children with Cerebral Palsy in Clinical Trial

Effect of Bone Marrow Mesenchymal Stem Cell on GMFM Scores of Children with Cerebral Palsy in Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-10000928
Enrollment
Unknown
Registered
2010-07-04
Start date
2009-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Interventions

Group A:Bone Marrow Mesenchymal Stem Cell transplantation

Sponsors

General Hospital of Chinese People's Armed Police Forces
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Signed informed consent document; 2. Patients with CP were aged between 6 months to 12 years old; 3. Gross Motor Function Classification System (GMFCS) levels IV, V; 4. Their parents accepted voluntarily stem cell transplantation for their children and followed-up.

Exclusion criteria

Exclusion criteria: 1. Have a history of severe allergic; 2. Serological tests such as AIDS, hepatitis B, syphilis, etc; 3. Hereditary metabolic diseases of nervous system; 4. Tumor or Hematological diseases.

Design outcomes

Primary

MeasureTime frame
GMFM, FMFM score;—

Countries

China

Contacts

Public ContactYihua An
riveran@163.com+86 13366881800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026